First Trust Advisors’s Impax Laboratories, Inc. IPXL Stock Holding History

First Trust Advisors’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-69,052	Closed	-$1.15M	–	2453
2017 Q4	$1.15M	Buy	+69,052	New	+$1.27M	﹤0.01%	1803
2017 Q1	–	Sell	-48,578	Closed	-$644K	–	2523
2016 Q4	$644K	Buy	+48,578	New	+$830K	﹤0.01%	2009
2016 Q2	–	Sell	-40,253	Closed	-$1.29M	–	2435
2016 Q1	$1.29M	Buy	40,253 +23,839	+145%	+$838K	﹤0.01%	1549
2015 Q4	$702K	Sell	16,414 -41,933	-72%	-$1.68M	﹤0.01%	1867
2015 Q3	$2.05M	Sell	58,347 -15,878	-21%	-$715K	0.01%	1382
2015 Q2	$3.41M	Buy	74,225 +36,796	+98%	+$1.75M	0.01%	1209
2015 Q1	$1.75M	Buy	+37,429	New	+$1.49M	0.01%	1548
2014 Q3	–	Sell	-60,757	Closed	-$1.82M	–	2342
2014 Q2	$1.82M	Sell	60,757 -56,319	-48%	-$1.52M	0.01%	1406
2014 Q1	$3.09M	Buy	+117,076	New	+$2.93M	0.01%	1166
2013 Q4	–	Sell	-12,625	Closed	-$258K	–	2291
2013 Q3	$258K	Buy	+12,625	New	+$261K	﹤0.01%	2136

Other funds holding IPXL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

TCW Group Los Angeles, California $13.3B AUM 34.44% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Trust Advisors's IPXL Position: Q1 2018 in Review

First Trust Advisors sold out of Impax Laboratories, Inc. (IPXL) in Q1 2018, closing a stake of 69,052 shares — an estimated $1.15M sold.

First Trust Advisors first reported a position in IPXL in Q3 2013 and held it in 10 quarters. The position peaked at $3.41M in Q2 2015. 188 funds tracked by Wall St. Rank hold IPXL as of Q1 2018.

First Trust Advisors reported no remaining Impax Laboratories, Inc. position as of Q1 2018 after selling out during the quarter.
First Trust Advisors sold 69,052 Impax Laboratories, Inc. shares in Q1 2018, an estimated $1.15M.
First Trust Advisors first reported a position in Impax Laboratories, Inc. in Q3 2013 and held it in 10 quarters.
First Trust Advisors's Impax Laboratories, Inc. position peaked at $3.41M in Q2 2015.
188 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q1 2018.

Based on First Trust Advisors's 13F filing for Q1 2018, filed 23 Apr 2018.